Page last updated: 2024-11-05

thiothixene and Parkinson Disease, Secondary

thiothixene has been researched along with Parkinson Disease, Secondary in 2 studies

Thiothixene: A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crowley, TJ1
Hydinger-Macdonald, M1
Itil, TM1
Patterson, CD1
Keskiner, A1
Holden, JM1

Trials

2 trials available for thiothixene and Parkinson Disease, Secondary

ArticleYear
Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
    Archives of general psychiatry, 1981, Volume: 38, Issue:6

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease, Se

1981
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
    Advances in biochemical psychopharmacology, 1974, Volume: 9, Issue:0

    Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female;

1974